| Initiation of hepatitis C virus infection requires the dynamic microtubule network: role of the viral nucleocapsid protein F Roohvand, P Maillard, JP Lavergne, S Boulant, M Walic, U Andreo, ... Journal of Biological Chemistry 284 (20), 13778-13791, 2009 | 106 | 2009 |
| Fcγ receptor-like activity of hepatitis C virus core protein P Maillard, JP Lavergne, S Sibéril, G Faure, F Roohvand, S Petres, ... Journal of Biological Chemistry 279 (4), 2430-2437, 2004 | 74 | 2004 |
| Severe acute respiratory syndrome‐coronavirus‐2 spike (S) protein based vaccine candidates: State of the art and future prospects A Arashkia, S Jalilvand, N Mohajel, A Afchangi, K Azadmanesh, ... Reviews in medical virology 31 (3), e2183, 2021 | 71 | 2021 |
| HCV core protein immunization with Montanide/CpG elicits strong Th1/Th2 and long-lived CTL responses F Roohvand, MR Aghasadeghi, SM Sadat, A Budkowska, AR Khabiri Biochemical and biophysical research communications 354 (3), 641-649, 2007 | 60 | 2007 |
| Advances in hepatitis C virus vaccines, part two: advances in hepatitis C virus vaccine formulations and modalities F Roohvand, N Kossari Expert opinion on therapeutic patents 22 (4), 391-415, 2012 | 59 | 2012 |
| Lipoprotein lipase inhibits hepatitis C virus (HCV) infection by blocking virus cell entry P Maillard, M Walic, P Meuleman, F Roohvand, T Huby, W Le Goff, ... PloS one 6 (10), e26637, 2011 | 55 | 2011 |
| Recombinant λ-phage nanobioparticles for tumor therapy in mice models A Ghaemi, H Soleimanjahi, P Gill, Z Hassan, SRM Jahromi, F Roohvand Genetic vaccines and therapy 8, 1-7, 2010 | 53 | 2010 |
| Biomedical applications of yeast-a patent view, part one: yeasts as workhorses for the production of therapeutics and vaccines F Roohvand, M Shokri, M Abdollahpour-Alitappeh, P Ehsani Expert opinion on therapeutic patents 27 (8), 929-951, 2017 | 51 | 2017 |
| Identification of a functional, CRM-1-dependent nuclear export signal in hepatitis C virus core protein A Cerutti, P Maillard, R Minisini, PO Vidalain, F Roohvand, EI Pecheur, ... PloS one 6 (10), e25854, 2011 | 50 | 2011 |
| Oral Administration of Recombinant Saccharomyces boulardii Expressing Ovalbumin-CPE Fusion Protein Induces Antibody Response in Mice G Bagherpour, H Ghasemi, B Zand, N Zarei, F Roohvand, EM Ardakani, ... Frontiers in microbiology 9, 723, 2018 | 48 | 2018 |
| Fusion of HBsAg and prime/boosting augment Th1 and CTL responses to HCV polytope DNA vaccine A Memarnejadian, F Roohvand Cellular immunology 261 (2), 93-98, 2010 | 48 | 2010 |
| Co-expression of hepatitis C virus polytope–HBsAg and p19-silencing suppressor protein in tobacco leaves S Mohammadzadeh, F Roohvand, A Memarnejadian, A Jafari, S Ajdary, ... Pharmaceutical biology 54 (3), 465-473, 2016 | 39 | 2016 |
| Advances in hepatitis C virus vaccines, Part one: Advances in basic knowledge for hepatitis C virus vaccine design F Roohvand, N Kossari Expert Opinion on Therapeutic Patents 21 (12), 1811-1830, 2011 | 39 | 2011 |
| Conjugated linoleic acid‐producing enzymes: A bioinformatics study J Farmani, M Safari, F Roohvand, SH Razavi, MR Aghasadeghi, ... European journal of lipid science and technology 112 (10), 1088-1100, 2010 | 32 | 2010 |
| Polytope DNA vaccine development against hepatitis C virus: a streamlined approach from in silico design to in vitro and primary in vivo analyses in BALB/c mice A Memarnejadian, F Roohvand, A Arashkia, S Rafati, MA Shokrgozar Protein and peptide letters 16 (7), 842-850, 2009 | 31 | 2009 |
| Comparing Montanide ISA 720 and 50-V2 adjuvants formulated with LmSTI1 protein of Leishmania major indicated the potential cytokine patterns for induction of protective immune … M Shokri, F Roohvand, MH Alimohammadian, M Ebrahimirad, S Ajdary Molecular immunology 76, 108-115, 2016 | 29 | 2016 |
| Design, modeling, expression, and chemoselective PEGylation of a new nanosize cysteine analog of erythropoietin RA Cohan, A Madadkar-Sobhani, H Khanahmad, F Roohvand, ... International journal of nanomedicine, 1217-1227, 2011 | 29 | 2011 |
| Optimization of transfection methods for Huh-7 and Vero cells: A comparative study A Hashemi, F Roohvand, MH Ghahremani, MR Aghasadeghi, ... Cytology and Genetics 46, 347-353, 2012 | 27 | 2012 |
| Construction of HCV-polytope vaccine candidates harbouring immune-enhancer sequences and primary evaluation of their immunogenicity in BALB/c mice A Arashkia, F Roohvand, A Memarnejadian, MR Aghasadeghi, S Rafati Virus genes 40, 44-52, 2010 | 27 | 2010 |
| Sindbis virus-pseudotyped lentiviral vectors carrying VEGFR2-specific nanobody for potential transductional targeting of tumor vasculature R Ahani, F Roohvand, RA Cohan, MH Etemadzadeh, N Mohajel, ... Molecular biotechnology 58, 738-747, 2016 | 26 | 2016 |
